Epitranscriptomic modification of RNA regulates human development, health, and disease.
The true diversity of the transcriptome in breast cancer including chemical modification of …

Osteosarcoma, originating from primitive bone-forming mesenchymal cells, is the most
common malignant bone tumour among children and adolescents. N6-methyladenosine …

Abstract m6A is an important RNA methylation in progression of various human cancers. As
the m6A reader protein, YTHDF1 is reported to accelerate m6A-modified mRNAs translation …

YTHDF1 is a well-characterized m6A reader protein that is essential for protein translation,
stem cell self-renewal, and embryonic development. YTHDF1 regulates target gene …

N6-methyladenosine (m6A) is the most abundant internal RNA modification in eukaryotic
cells, which participates in the functional regulation of various biological processes. It …

Abstract N6-methyladenosine (m6A) modification, catalyzed by methyltransferase
complexes (MTCs), plays many roles in multifaceted biological activities. As the most …

Background As one of the most ubiquitous types of posttranscriptional modification, N6-
methyladenosine (m6A) is extensively implicated in almost all types of cancers, including …

Skeletal system disease (SSD) is defined as a class of chronic disorders of skeletal system
with poor prognosis and causes heavy economic burden. m6A, methylation at the N6 …

Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host
response to infection. It is characterized by high morbidity and mortality and one of the major …

Abstract The N6‐methyladenosine (m6A) RNA modification has gained significant
prominence as a new layer of regulatory mechanism that governs gene expression. Over the …